Cart

“Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs PDF” has been added to your cart. View cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item	Thumbnail image	Product	Price	Quantity	Subtotal
×		Self-Harm in Sertraline-Induced Akathisia \| Psychiatrist.com PDF	$40.00	Self-Harm in Sertraline-Induced Akathisia \| Psychiatrist.com PDF quantity	$40.00
×		Nonadherence With Mood Stabilizers: Prevalence and Predictors. PDF	$40.00	Nonadherence With Mood Stabilizers: Prevalence and Predictors. PDF quantity	$40.00
×		Bereavement, Complicated Grief, and DSM, Part 1: Depression PDF	$40.00	Bereavement, Complicated Grief, and DSM, Part 1: Depression PDF quantity	$40.00
×		Clinical Experience With Gabapentin in Patients With Bipolar or Schizoaffective Disorder: Results of an Open-Label Study PDF	$40.00	Clinical Experience With Gabapentin in Patients With Bipolar or Schizoaffective Disorder: Results of an Open-Label Study PDF quantity	$40.00
×		Psychiatric Care of the Patient With Hepatitis C: A Review of the Literature PDF	$40.00	Psychiatric Care of the Patient With Hepatitis C: A Review of the Literature PDF quantity	$40.00
×		Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs PDF	$40.00	Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs PDF quantity	$40.00
Coupon:

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.

Cart totals

Subtotal	$240.00
Total	$240.00

Proceed to checkout